Skip to main content

Table 1 General characteristics and descriptive data of the studied groups of carriers or non-carriers of "I" allele of ACE gene (n = 30).

From: The higher exercise intensity and the presence of allele I of ACE gene elicit a higher post-exercise blood pressure reduction and nitric oxide release in elderly women: an experimental study

 

I/D-I/I

D/D

p

   N

10/10

10

-

   Age (years)

70.4 ± 6.2

70.6 ± 5.8

0.93

   Weight (kg)

60.6 ± 8.4

60.0 ± 9.1

0.86

   Height (cm)

153.1 ± 7.1

153.7 ± 4.7

0.82

   BMI (kg·m-2)

25.9 ± 3.0

25.4 ± 3.2

0.70

Metabolic and Hemodynamic Variables

   

   Glycaemia (mg·dL-1)

86.9 ± 13.1

79.6 ± 17.1

0.21

   SBP IT rest (mm·Hg-1)

129.0 ± 17.0

125.0 ± 14.0

0.47

   DBP IT rest (mm·Hg-1)

77.0 ± 8.0

77.0 ± 7.0

0.87

   NO2 - rest (μM)

294.4 ± 176.5

278.2 ± 159.0

0.81

Performance data of IT and 90%AT

   

   Watts peak IT (Watts)

62.3 ± 21.4

57.0 ± 19.7

0.52

   Watts at AT (Watts)

38.4 ± 14.4

39.6 ± 14.8

0.83

   Watts at 90%AT (Watts)

34.5 ± 13.0

35.6 ± 13.3

0.83

   VO2peak IT (mL·kg-1·min-1)

20.5 ± 4.3

20.1 ± 3.0

0.78

   VO2 at 90%AT(mL·kg-1·min-1)

14.8 ± 2.3

15.8 ± 3.3

0.37

   HRpeak IT (bpm)

148.0 ± 21.0

142.7 ± 19.6

0.51

   HR at 90%AT (bpm)

119.5 ± 15.8

116.8 ± 17.6

0.68

   [Lac] peak (mM)

4.8 ± 1.9

4.4 ± 1.4

0.54

   [Lac] 90%AT (mM)

3.0 ± 1.1

3.3 ± 1.2

0.42

   RPE peak IT (Borg)

17.6 ± 1.5

18.1 ± 1.6

0.41

   RPE at 90%LA (Borg)

13.2 ± 2.0

13.8 ± 1.2

0.42

   Diuretics Medication (% of volunteers)

20.0

20.0

-

  1. I/D-I/I and D/D - angiotensin converting enzyme (ACE) genotype; BMI - body mass index, SBP - systolic blood pressure, DBP - diastolic blood pressure, NO2 - - nitrite concentration, VO2peak: peak oxygen consumption reached in IT; VO2: oxygen consumption; HRpeak: peak heart rate reached in IT; HR: heart rate; [Lac] peak: peak lactate concentration reached in IT; [Lac]: lactate concentration; RPE peak: peak rate of perceived exertion reached in IT; RPE: rate of perceived exertion.